Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 29, Number 6—June 2023
Research

SARS-CoV-2 Vaccine Effectiveness against Omicron Variant in Infection-Naive Population, Australia, 2022

Lauren E. Bloomfield, Sera Ngeh, Gemma Cadby, Kate Hutcheon, and Paul V. EfflerComments to Author 
Author affiliations: The University of Notre Dame Australia, Fremantle, Western Australia, Australia (L.E. Bloomfield); Western Australia Department of Health, East Perth, Western Australia, Australia (L.E. Bloomfield, S. Ngeh, G. Cadby, K. Hutcheon, P.V. Effler)

Main Article

Table 1

Clinician specialties for which hospital admissions were excluded from the analysis of SARS-CoV-2 vaccine effectiveness, Western Australia, Australia, February 1, 2022–May 31, 2022

Specialty
Child psychiatry/psychology
In vitro fertilization
Gynecology oncologist
Oncology
Psychogeriatrics
Psychiatry
Radiology
Nephrology/dialysis
Obstetrics
Burns
Dental surgery
Gynecology
Ophthalmology
Oral surgery
Orthopedics
Plastic and reconstructive surgery
Renal transplant surgery
Spinal surgery
Radiation oncology
General practitioner obstetrics

Main Article

Page created: April 19, 2023
Page updated: May 17, 2023
Page reviewed: May 17, 2023
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external